Injective (INJ) is trading at $7.07 on Binance spot as of October 10, 2026, already below the $7.33 level that analyst Ali Martinez identified on October 5 as the threshold buyers must defend for a(Read More) ... .
INJ sits at $7.52 with momentum dead in the water and aggressive sell-side order flow dominating short-term action — yet top-trader positioning is 58.6% long. A clean hold above $7.35 sets up a run(Read More) ... .
INJ ETFs to launch before 2027, saying the process is moving faster than he anticipated ... the 21Shares Injective ETF and Canary Staked INJ ETF, with both issuers filing amended S-1 statements in September.
At the Inje Speedium, the **'TCRWorld Tour'**, a global touring car championship, and the **'Hyundai N Festival'**, South Korea’s largest one-make race, were being held simultaneously.
INJ sits at $7.56 with its MACD histogram at dead zero and open interest bleeding 4.78% — yet top traders are 60.5% long, creating a textbook smart money vs. retail divergence. The next 7–30 days h(Read More) ... .
INJ is coiled at a critical pivot with MACD momentum completely exhausted and retail sellers hammering short-term flow, but smart money is quietly loading the long side — a decisive reclaim of $7.8(Read More) ... .
) In the fast-moving world of cryptocurrency, teams constantly dump tokens into the market through emissions and incentives ... [...]. This is an abstract of the document.
Injective is trading at $7.71 with top-tier traders sitting 60% long and all major moving averages stacked bullishly beneath current price — but momentum has gone flat at a critical resistance clus(Read More) ... .
INJ is coiling just beneath the $7.98–$8.16 resistance cluster three days after the Meridian mainnet upgrade went live, with smart money leaning long but momentum dead flat — a decisive break above(Read More) ... .